Articles
How will you measure success in 2011?

How will you measure success in 2011?

With technological advances we gain access to faster and improved data and with this a clearer picture of performance indicators. With these advances available, Richard Jenkinson asks how we will be measuring success next year. For many years, pharmaceutical companies have relied on Key Performance Indicators (KPIs) such as…

Articles
What Are IDEAs Made Of: Hurdles

What Are IDEAs Made Of: Hurdles

There are many hurdles preventing a drug from getting to market and unfortunately they’re not always clearly defined. Mike Rea questions how truly innovative products can proceed in such an unknown world. Measuring how well a drug works is not easy. The regulators like to put hurdles out - if the drug jumps them all cleanly...

Articles
Where is the value in a pharmaceutical sales conversation?

Where is the value in a pharmaceutical sales conversation?

The topics that physicians would most like to discuss are usually out of bounds in pharma sales conversations. Where then, Erroin Martin asks, is the value in them? Twentieth Century Fox released a movie about a month ago titled “Love And Other Drugs.” The film is about a pharmaceutical salesman who…

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more